Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Wyeth Seeks Approval To Launch 2 Drugs In Japan By 2007 End (Japan)

This article was originally published in PharmAsia News

Executive Summary

Wyeth is seeking marketing approval to introduce two prescription drugs in Japan. The company will file a new drug application with the Japanese government for Tygacil and Viviant by the end of this year. Viviant is used for osteoporosis, while Tygacil is used to treat pneumonia and other infections. The new drug launches are part of Wyeth's aim to raise sales in Japan to $1 billion by 2010, nearly double that of 2006. (Click here for more - May Require Paid Subscription



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts